(Q40883792)

24 September 2017

title

Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose (English)

1 reference

24 September 2017

1 reference

Ruffin MT 4th

1

1 reference

24 September 2017

Krishnan K

2

1 reference

24 September 2017

Rock CL

3

1 reference

24 September 2017

Normolle D

4

1 reference

24 September 2017

Vaerten MA

5

1 reference

24 September 2017

Peters-Golden M

6

1 reference

24 September 2017

Crowell J

7

1 reference

24 September 2017

Kelloff G

8

1 reference

24 September 2017

Boland CR

9

1 reference

24 September 2017

Brenner DE

10

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 August 1997

1 reference

Journal of the National Cancer Institute

24 September 2017

published in

1 reference

24 September 2017

volume

89

1 reference

24 September 2017

issue

15

1 reference

24 September 2017

page(s)

1152-1160

1 reference

Effects of aspirin on 1, 2-dimethylhydrazine-induced colonic carcinogenesis

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Aspirin reduces the incidence of colonic carcinoma in the dimethylhydrazine rat animal model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Effect of aspirin on incidence and growth of aberrant crypt foci induced in the rat colon by 1,2-dimethylhydrazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

A protective effect of sulindac against chemically-induced primary colonic tumours in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Aspirin use and reduced risk of fatal colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Nonsteroidal antiinflammatory drugs and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Aspirin use and chronic diseases: a cohort study of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Mechanism of inhibition of tumour growth by aspirin and indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Role of local prostaglandin synthesis in the modulation of proliferative activity of rat colonic epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Relationship between blood plasma prostaglandin E2 and liver and lung metastases in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Effects of early intervention with low-dose aspirin (100 mg) on infarct size, reinfarction and mortality in anterior wall acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Biomarkers as intermediate end points in chemoprevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

Incidence of Cancer Among Patients With Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2F89.15.1152

21 January 2018

Identifiers

DOI

10.1093/JNCI/89.15.1152

1 reference

24 September 2017

1 reference